{
    "organizations": [],
    "uuid": "92d2610d2ebb04f406657a6492aac41cdab75938",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-spimaco-signs-mou-with-astrazeneca/brief-spimaco-signs-mou-with-astrazeneca-idUSFWN1QP0ZR",
    "ord_in_thread": 0,
    "title": "BRIEF-SPIMACO Signs MoU With Astrazeneca",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORP:\n* SIGNS MOU WITH ASTRAZENECA, TARGETS INVESTMENT, TECHNOLOGY TRANSFER, MANUFACTURING RANGE OF PHARMACEUTICALS UNDER PROJECT OF PRODUCING MEDICINES FOR CANCER DISEASES\n* ESTIMATED COST FOR PROJECT OF PRODUCING MEDICINES FOR CANCER DISEASES BASED ON CURRENT STUDIES TO REACH 245 MILLION RIYALS\n* EXPECTS TO COMPLETE PROJECT BY END OF Q3 2019 Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T13:56:00.000+02:00",
    "crawled": "2018-03-09T14:32:37.053+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "saudi",
        "pharmaceutical",
        "industry",
        "medical",
        "appliance",
        "corp",
        "sign",
        "mou",
        "astrazeneca",
        "target",
        "investment",
        "technology",
        "transfer",
        "manufacturing",
        "range",
        "pharmaceutical",
        "project",
        "producing",
        "medicine",
        "cancer",
        "disease",
        "estimated",
        "cost",
        "project",
        "producing",
        "medicine",
        "cancer",
        "disease",
        "based",
        "current",
        "study",
        "reach",
        "million",
        "riyal",
        "expects",
        "complete",
        "project",
        "end",
        "q3",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}